Back

PI3 kinase-unrelated effects of LY294002 and LY303511 on serotonin-induced Ca2+ and cAMP signaling

Kotova, P. D.; Dymova, E. A.; Rogachevskaja, O. A.; Kolesnikov, S. S.

2024-05-05 pharmacology and toxicology
10.1101/2024.05.05.592569 bioRxiv
Show abstract

The phosphoinositide 3-kinase (PI3K) is involved in regulation of multiple intracellular processes. Although the inhibitory analysis is generally employed for validating a physiological role of PI3K, increasing body of evidence suggests that PI3K inhibitors can exhibit PI3K-unrelated activity as well. Here we studied effects of PI3K inhibitor LY294002 and its inactive analogue LY303511 on Ca2+ and cAMP signals initiated by serotonin. In the present study several monoclonal HEK293 cell lines were used, in particular, monitoring of Ca2+ signals were carried out on Fura-2 loaded cells expressed recombinant serotonin 5-HT2C receptors, cAMP signals were studied on cells expressed the genetically encoded cAMP sensor Pink Flamindo and recombinant 5-HT4 receptors, for monitoring PI3K activity cells stably expressed the genetically encoded PIP3 sensor PH(Akt)-Venus were used. It turned out that LY294002 suppressed Ca2+ signals initiated by activation 5-HT2C receptors irrespectively of PI3K inhibition, but did not affect cAMP responses initiated by 5-HT4 receptors. In turn LY303511 suppressed cAMP signals initiated by 5-HT4 receptors, and elicited Ca2+ transients exclusively in cells expressed 5-HT2C receptors. Based on these facts and the results of the inhibitory analysis, we hypothesize that the described effects may be due to the activity of LY294002 and LY303511 on the serotonin 5-HT2C and 5-HT4 receptors.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Frontiers in Pharmacology
100 papers in training set
Top 0.1%
18.9%
2
PLOS ONE
4510 papers in training set
Top 12%
14.9%
3
Scientific Reports
3102 papers in training set
Top 12%
7.3%
4
British Journal of Pharmacology
34 papers in training set
Top 0.1%
6.9%
5
ACS Pharmacology & Translational Science
40 papers in training set
Top 0.1%
6.5%
50% of probability mass above
6
Biochemical Pharmacology
18 papers in training set
Top 0.1%
4.9%
7
International Journal of Molecular Sciences
453 papers in training set
Top 2%
4.0%
8
European Journal of Pharmacology
11 papers in training set
Top 0.1%
2.6%
9
Pharmaceuticals
33 papers in training set
Top 0.3%
2.5%
10
Biomedicines
66 papers in training set
Top 0.5%
2.1%
11
Neuropharmacology
60 papers in training set
Top 0.4%
1.7%
12
ACS Chemical Neuroscience
60 papers in training set
Top 1%
1.5%
13
Life Sciences
25 papers in training set
Top 0.7%
1.3%
14
Frontiers in Neuroscience
223 papers in training set
Top 5%
1.2%
15
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
28 papers in training set
Top 0.3%
1.2%
16
Gene
41 papers in training set
Top 2%
1.0%
17
Biomolecules
95 papers in training set
Top 1%
1.0%
18
Neuroscience Letters
28 papers in training set
Top 0.9%
0.9%
19
The Journal of Pharmacology and Experimental Therapeutics
15 papers in training set
Top 0.3%
0.9%
20
The Journal of Steroid Biochemistry and Molecular Biology
10 papers in training set
Top 0.3%
0.9%
21
F1000Research
79 papers in training set
Top 4%
0.8%
22
Heliyon
146 papers in training set
Top 6%
0.8%
23
Cellular Signalling
14 papers in training set
Top 0.2%
0.8%
24
Biochimica et Biophysica Acta (BBA) - General Subjects
16 papers in training set
Top 0.2%
0.8%
25
Journal of Clinical Medicine
91 papers in training set
Top 7%
0.7%
26
Psychopharmacology
59 papers in training set
Top 0.7%
0.7%
27
ACS Omega
90 papers in training set
Top 5%
0.7%
28
PeerJ
261 papers in training set
Top 17%
0.7%
29
Journal of Psychopharmacology
14 papers in training set
Top 0.8%
0.5%